Global AI based Clinical Trial Solution provider market
報告摘要
The global Global AI based Clinical Trial Solution provider market- Market is projected to witness notable expansion over the coming years.
The AI based Clinical Trial Solution provider market- sector involves The process, clinical trials are a very crucial that enable both innovators and regulators to assess the efficacy of a candidate drug, use of AI in clinical trial save the time and cost efficiencies b. This domain has witnessed notable transformation owing to technological breakthroughs and shifting technology and communications dynamics.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the technology and communications sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Artificial Intelligence is set of smart technologies that develop and learn from data and perform tasks based on previous experience. The process, clinical trials are a very crucial that enable both innovators and regulators to assess the efficacy of a candidate drug, use of AI in clinical trial save the time and cost efficiencies by providing faster insights to form the decision. AI helps Investigator to answer some questions inlcuding how to consuct study design, site identification & patient recruitment for clinical research and to digitize adverse drug reaction (ADR) documents in pharmacovigilance. The successfully developing a novel therapeutic intervention required around 10 years of time and cost around USD 2.5 billion, However, use of technology like artificial intelligent in clinical trial help to save huge amount of money as well as time.
Increasing number of strategic alliances in deployment of Artificial Intelligence (AI) in clinical trials aims to reduce time as well expenditure during clinical developmental phases is expected to create the lucrative growth in market near the future. Additionally, Regulators around the world have released guideline that encourage biopharma companies to use real world evidence strategies. For instance, US FDA has passed the 21st Century Cures Act, in 2016, that was designed to help bring new innovations and advances to patients more efficiently and faster.
The Global AI-Based Clinical Trial Solution Provider market is segmented on the basis of target therapeutic area, trial phase, end users and region. Based on the therapeutic area, the market is divided into cardiovascular disorders, cns disorders, infectious disorders, metabolic disorders, oncological disorders and other disorders. Based on the trial phase, the market is divided into early phase 1, phase 1, phase 2, phase 3 and phase 4. Based on the end users, the market is divided into pharmaceutical companies, academia and other users. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of forecast period.
The key players of this market include Antidote Technologies, Inc., AiCure, LLC, Deep 6 AI, Deep Lens Inc., Innoplexus, Intelligencia.ai, MEDIAN Technologies, Mendel.ai, Phesi, Saama Technologies, Unlearn.AI, Inc. and Trials.ai
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們